Search Results 191-200 of 11787 for ���������������������������:za33���24������ ������������������������ ������

  1. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo neuroscientists discover unknown brain area involved in movement May 24, 2023, 03:00 p.m. CDT. Products & Services. A Book: Mayo Clinic Family Health ...

  2. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo neuroscientists discover unknown brain area involved in movement May 24, 2023, 03:00 p.m. CDT. Products & Services. A Book: Mayo Clinic Family Health ...

  3. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo neuroscientists discover unknown brain area involved in movement May 24, 2023, 03:00 p.m. CDT. Products & Services. A Book: Mayo Clinic Family Health ...

  4. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II) - Mayo Clinic

    ... 24 hours on the serial computed tomographic (CT) scans. Assess the safety of the intensive treatment relative to the standard treatment in the proportion of ...

  5. A Study of Patient Centered Approaches to Gene Editing - Mayo Clinic

    Overview. Tab Title Description. Study IDs. Study IDs. Site IRB. Rochester, Minnesota: 24-005545; Jacksonville, Florida: 24-005545. About this study. The ...

  6. Radiation Oncology - Referrals - Mayo Clinic

    Telephone consultations are available in most medical and surgical specialties at Mayo Clinic 24 hours a day, seven days a week. Call the Referring Provider ...

  7. Supraventricular tachycardia - Diagnosis and treatment - Mayo Clinic

    American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/about-arrhythmia/tachycardia--fast-heart-rate. Accessed Jan. 24, 2024. 2020-2025 ...

  8. IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma - Mayo Clinic

    Rochester, Minnesota: 24-000858. NCT ID: NCT05987332. Sponsor Protocol Number: IDE196-002. About this study. The purpose of this study is to compare IDE196 + ...

  9. Publications

    2019 Oct; 24 (5):442-451 Epub 2019 July 27. View PubMed; Misra S, Shishehbor MH, Takahashi EA, Aronow HD, Brewster LP, Bunte MC, Kim ESH, Lindner JR, Rich K ...

  10. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-011889; Jacksonville, Florida: 24-011889. NCT ID: NCT06158841. Sponsor Protocol Number: M22-574. About this study. The purpose ...